Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Merck
MRK
|
+$362M |
| 2 |
Prologis
PLD
|
+$358M |
| 3 |
NVIDIA
NVDA
|
+$305M |
| 4 |
Corteva
CTVA
|
+$235M |
| 5 |
Atlassian
TEAM
|
+$226M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.8B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$308M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$261M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$259M |
| 5 |
Danaher
DHR
|
+$243M |
Sector Composition
| 1 | Technology | 22.57% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
MBIA
MBI
$387M
| $2.12M | ﹤0.01% |
164,984
-20,421
| -11% | -$262K |
|
2327
Bank of Marin Bancorp
BMRC
$403M
| $2.12M | ﹤0.01% |
64,419
-4,663
| -7% | -$153K |
|
|
HAYN
2328
DELISTED
Haynes International, Inc.
HAYN
| $2.11M | ﹤0.01% |
46,243
+2,057
| +5% | +$94K |
|
2329
National Research Corp
NRC
$372M
| $2.11M | ﹤0.01% |
56,487
-1,363
| -2% | -$50.8K |
|
2330
Tejon Ranch
TRC
$455M
| $2.11M | ﹤0.01% |
111,877
-9,438
| -8% | -$178K |
|
2331
Zumiez
ZUMZ
$363M
| $2.1M | ﹤0.01% |
96,733
-7,981
| -8% | -$174K |
|
2332
Vanguard FTSE Developed Markets ETF
VEA
$175B
| $2.1M | ﹤0.01% |
50,000
| – | – |
|
2333
Hackett Group
HCKT
$586M
| $2.1M | ﹤0.01% |
102,848
-14,108
| -12% | -$287K |
|
2334
Telos
TLS
$510M
| $2.08M | ﹤0.01% |
188,770
+51,438
| +37% | +$568K |
|
2335
Tootsie Roll Industries
TR
$2.91B
| $2.08M | ﹤0.01% |
53,442
-968
| -2% | -$37.7K |
|
|
GOOD
2336
Gladstone Commercial Corp
GOOD
$610M
| $2.08M | ﹤0.01% |
112,418
-6,748
| -6% | -$125K |
|
2337
Anika Therapeutics
ANIK
$125M
| $2.07M | ﹤0.01% |
69,792
+15,079
| +28% | +$446K |
|
2338
WisdomTree
WT
$2.07B
| $2.06M | ﹤0.01% |
378,678
-21,717
| -5% | -$118K |
|
2339
Trustco Bank Corp NY
TRST
$755M
| $2.06M | ﹤0.01% |
54,738
-8,673
| -14% | -$326K |
|
2340
SI-BONE Inc
SIBN
$701M
| $2.05M | ﹤0.01% |
151,037
+56,126
| +59% | +$763K |
|
2341
Anavex Life Sciences
AVXL
$823M
| $2.05M | ﹤0.01% |
221,080
-50,375
| -19% | -$467K |
|
2342
Steelcase
SCS
$1.95B
| $2.05M | ﹤0.01% |
289,394
-131,189
| -31% | -$927K |
|
2343
Xperi
XPER
$280M
| $2.04M | ﹤0.01% |
+237,137
| New | +$2.04M |
|
2344
Xenon Pharmaceuticals
XENE
$2.87B
| $2.02M | ﹤0.01% |
51,280
+920
| +2% | +$36.3K |
|
2345
Lemonade
LMND
$3.73B
| $2.02M | ﹤0.01% |
147,372
-20,401
| -12% | -$279K |
|
|
NWLI
2346
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $2.01M | ﹤0.01% |
7,138
-1,277
| -15% | -$359K |
|
|
SQSP
2347
DELISTED
Squarespace, Inc.
SQSP
| $2.01M | ﹤0.01% |
90,432
-15,498
| -15% | -$344K |
|
2348
National Healthcare
NHC
$1.79B
| $1.99M | ﹤0.01% |
33,508
-5,469
| -14% | -$325K |
|
2349
Greif Class B
GEF.B
$2.49B
| $1.99M | ﹤0.01% |
25,431
+1,408
| +6% | +$110K |
|
2350
Cass Information Systems
CASS
$574M
| $1.99M | ﹤0.01% |
43,322
-7,355
| -15% | -$337K |
|